SMTL ID : 7f7w.1 (1 other biounit)

JAK2-JH2

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.83 Å

Oligo State

monomer

Ligands

1 x 36H: 2-((1-(2-fluoro-4-((4-(1-isopropyl-1H-pyrazol-4-yl)-5-methylpyrimidin-2-yl)amino)phenyl)piperidin-4-yl)(methyl)amino)ethan-1-ol(Non-covalent)

36H.1: 21 residues within 4Å: Chain A: L.16, Q.18, G.19, T.22, I.24, L.44, K.46, V.75, Q.91, E.92, F.93, V.94, K.95, F.96, G.97, S.98, T.101, K.142, N.143, L.145, S.163 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:I.24, A:L.44, A:V.75, A:F.93, A:L.145 Hydrogen bonds: A:K.46, A:V.94, A:V.94

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hu, M. et al., Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F -induced myeloproliferative neoplasms. Blood Cancer J (2022)

Release Date

2022-03-30

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence